Covered recipient · General Payments record
DIVINA GRACIA ROSALES MURAO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2025
$1,497.97
- Reported across 62 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,236.99 | 59 |
| Education | $260.98 | 3 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $169.49 | 6 |
| Daiichi Sankyo Inc. | $119.46 | 2 |
| Merck Sharp & Dohme Corporation | $97.64 | 4 |
| PFIZER INC. | $86.27 | 7 |
| Bayer HealthCare Pharmaceuticals Inc. | $85.81 | 4 |
| SEAGEN INC. | $77.99 | 1 |
| TerSera Therapeutics LLC | $74.41 | 2 |
| Exelixis Inc. | $67.19 | 4 |
| SOBI, INC | $66.07 | 3 |
| ARRAY BIOPHARMA INC | $61.69 | 3 |
| Acerta Pharma LLC | $52.84 | 3 |
| Genmab U.S., Inc. | $52.07 | 2 |
| RECORDATI_RARE_DISEASES_INC. | $51.35 | 2 |
| ABBVIE INC. | $49.65 | 2 |
| Sumitomo Pharma America, Inc. | $39.75 | 2 |
| Genentech USA, Inc. | $37.54 | 2 |
| Stemline Therapeutics Inc. | $35.60 | 2 |
| EISAI INC. | $34.06 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $33.23 | 1 |
| E.R. Squibb & Sons, L.L.C. | $32.51 | 1 |
| TAIHO ONCOLOGY, INC. | $31.50 | 1 |
| Rigel Pharmaceuticals, Inc. | $30.85 | 1 |
| Iovance Biotherapeutics, Inc. | $25.31 | 1 |
| Regeneron Healthcare Solutions, Inc. | $23.35 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.23 | 1 |
| Janssen Biotech, Inc. | $20.98 | 1 |
| Apellis Pharmaceuticals, Inc. | $19.13 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $1,497.97 | 62 |
Payment records · PY2025 (62)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.